Hemophagocytic syndrome: A misleading complication of visceral leishmaniasis in children: A series of 12 cases
Gagnaire M-H, Galambrun C, Stephan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children: a series of 12 cases. Pediatrics. 2000;106:e58.
Hemophagocytic syndrome: A rare life-threatening complication of visceral leishmaniasis in a young boy
Tune B, Ayata A. Hemophagocytic syndrome: a rare life-threatening complication of visceral leishmaniasis in a young boy. Pediatr Hematol Oncol. 2001;18:531-536.
Review: Molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification
Schallig HDFH, Oskam L. Review: molecular biological applications in the diagnosis and control of leishmaniasis and parasite identification. Tropic Med Int Health. 2002;7:641-651.
Diagnostic guidelines for hemophagocytic lymphohistiocytosis
Henter JI, Elinder G, Ost A, and the FHL Study Group of the Histiocyte Society. Diagnostic guidelines for hemophagocytic lymphohistiocytosis. Semin Oncol. 1991;18:29-33.
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients
Minodier P, Retornaz K, Horelt A, Gamier J-M. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients. Fundam Clin Pharmacol. 2003;17:183-188.